OxThera Company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Estimated Revenue:
$10M to $50M
Funding Status:
Late Stage Venture
Industry:
PharmTech
Investors Number:
10
Technology:
Others
Founded Date:
2005
Investor Type:
For Profit
Headquarters:
Stockholm, Stockholms Lan, Sweden
Total Funding:
€4.9M
Last Funding Type:
Seed
Employee Number:
11-50